Rockefeller Capital Management
RXDX

Rockefeller Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Rockefeller Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-39
Closed -$4K – 4160
2022
Q4 		$4K Hold
39
– – ﹤0.01% 3416
2022
Q3 		$2K Hold
39
– – ﹤0.01% 3650
2022
Q2 		$1K Buy
+39
New +$1K ﹤0.01% 4061